BackIveda Solutions Overview

Iveda Solutions Other Current Liabilities

Latest other current liabilities for IVDA: $800K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$799746.00
4.84% YoYΔ $-40717.00 vs prior year quarter

Peer trimmed avg / median

Loading

Iveda Solutions Other Current Liabilities History

Loading

Iveda Solutions vs. peers: Other Current Liabilities Comparison

Loading

Iveda Solutions Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Iveda Solutions (IVDA) FAQ

Iveda Solutions posts a other current liabilities of $800K as of June 2026. That compares with $840K in the prior-year period — down 4.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Iveda Solutions's other current liabilities was $840K. The latest reading is $800K — a 4.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Iveda Solutions's financial statement story. At $800K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IVDA's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Iveda Solutions's other metric pages and overview cover the third.

Judging Iveda Solutions against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $800K here, then scan peer and history charts to see if the gap is persistent.